Full Text View
Tabular View
No Study Results Posted
Related Studies
Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion (CHIC-3)
This study is currently recruiting participants.
Verified February 2013 by Centre Hospitalier Intercommunal Creteil
Study NCT01448018   Information provided by Centre Hospitalier Intercommunal Creteil

First Received on September 29, 2011.   Last Updated on February 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Central Retinal Vein Occlusion
Additional conditions recognized in this trial
Retinal Vein Occlusion
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Eye Diseases
Retinal Diseases
Thrombosis
Vascular Diseases
Venous Thrombosis
Interventions listed in this trial
ranibizumab
hemodilution
Sponsors listed in this trial
Centre Hospitalier Intercommunal Creteil


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services